Total Funding
50
58
Total FundingPost-IPO Debt raised
Growth Score
-5 pts
Heat Score
-16 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
115627
Spectral Medical focuses on the development and commercialization of a treatment for septic shock.
Chris Seto: Chief Executive Officer- John Kellum: Chief Medical OfficerPast Role: University of Pittsburgh, Director of the Center for Critical Care Nephrology
About the Company
Spectral Medical focuses on the development and commercialization of a treatment for septic shock using its endotoxin activity assay (EAA) diagnostic and the toraymyxin therapeutic.
